Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Ciênc. Saúde Colet. (Impr.) ; 20(2): 441-448, fev. 2015. tab
Artículo en Portugués | LILACS | ID: lil-742219

RESUMEN

Objetivou-se analisar as internações por condições sensíveis à atenção primária (ICSAP) específicas em mulheres e os fatores que determinam ou influenciam a ocorrência dessas internações (fatores socioeconômicos, sociodemográficos e controle de saúde) por meio de um inquérito de morbidade hospitalar realizado com amostra de 429 mulheres internadas em hospitais conveniados ao Sistema Único de Saúde. O percentual de ICSAP foi 49,42% (n = 212), com destaque para as internações específicas do sexo feminino 19,35% (n = 83). Associaram ao risco de internar por CSAP: idade superior a 60 anos, baixa escolaridade, internação prévia, realização de controle regular de saúde, falta de vínculo com a Estratégia Saúde da Família (ESF) e ser gestante. As causas evidentes foram as condições relacionadas à gravidez, ao parto e ao puerpério e às inflamações nos órgãos pélvicos femininos. Os resultados sugerem falhas no atendimento ambulatorial que deveria ser oportuno e resolutivo no contexto da saúde da mulher.


The scope of this paper was to analyze female-specific sensitive hospitalization occurring in primary care conditions and factors that determine or affect the occurrence of such hospitalizations (social, economic and demographic factors; health control). Analysis was performed by surveys on hospital morbidity with a sample of 429 females attended in Unified Health System (SUS) contracted hospitals. The sensitive hospitalizations percentage in primary care reached 49.42% (n = 212), highlighting female-specific hospitalization at 19.35% (n = 83). Hospitalization risks comprised elderly people over sixty, low schooling, previous hospitalizations, normal health control, lack of association with the Family Health Strategy and pregnancy. Evident causes were related to conditions of pregnancy, childbirth, post-partum and inflammations of the female pelvic organs. Results suggested flaws in outpatient attendance that should be adequate and provide solutions in women’s health.


Asunto(s)
Humanos , Lactante , Proteínas Bacterianas/inmunología , Proteínas Portadoras/inmunología , Vacuna contra Difteria, Tétanos y Tos Ferina/efectos adversos , Vacuna contra Difteria, Tétanos y Tos Ferina/inmunología , Vacunas contra Haemophilus/efectos adversos , Vacunas contra Haemophilus/inmunología , Inmunoglobulina D/inmunología , Lipoproteínas/inmunología , Vacunas Neumococicas/efectos adversos , Vacunas Neumococicas/inmunología , Vacuna Antipolio de Virus Inactivados/efectos adversos , Vacuna Antipolio de Virus Inactivados/inmunología , Anticuerpos Antibacterianos/inmunología , Anticuerpos Antivirales/inmunología , Vacuna contra Difteria, Tétanos y Tos Ferina/administración & dosificación , Vacunas contra Haemophilus/administración & dosificación , Esquemas de Inmunización , Países Bajos , Vacunas Neumococicas/administración & dosificación , Vacuna Antipolio de Virus Inactivados/administración & dosificación , Vacunación , Vacunas Combinadas/administración & dosificación , Vacunas Combinadas/efectos adversos , Vacunas Combinadas/inmunología , Vacunas Conjugadas
2.
Pediatria (Säo Paulo) ; 19(1): 9-23, jan.-mar. 1997. ilus, tab
Artículo en Portugués | LILACS | ID: lil-198623

RESUMEN

O conhecimento da imunidade do feto e do recem-nascido e de grande importancia, por estar diretamente relacionado com a susceptibilidade deste, frente a processos infecciosos. Apresentamos uma revisao da literatura focalizando a imunidade humoral, celular, o sistema complemento e a atividade das celulas fagocitarias, chamando atencao para os aspectos mais importantes que poderao ser uteis na escolha de uma terapeutica imunologica adequada


Asunto(s)
Humanos , Recién Nacido , Feto/inmunología , Inmunidad Materno-Adquirida , Recién Nacido/inmunología , Formación de Anticuerpos , Actividad Bactericida de la Sangre/inmunología , Quimiotaxis , Fibronectinas/inmunología , Inmunidad Celular , Inmunidad Innata , Inmunoglobulina A/inmunología , Inmunoglobulina D/inmunología , Inmunoglobulina E/inmunología , Inmunoglobulina M/inmunología , Inmunoglobulinas , Fagocitosis/inmunología
3.
Artículo en Inglés | IMSEAR | ID: sea-119872

RESUMEN

BACKGROUND. The Institute of Immunohaematology has had an Rh clinic at the Nowrosjee Wadia Maternity Hospital since 1957. Between then and 1977, 5% Rh-negative women produced Rh antibodies. Between 1978 and 1980, the rate of immunization was reduced to 3.3%. In the present study we determined the incidence of Rh immunization between 1981 and 1992. METHODS. ABO and Rh grouping was carried out by standard methods on 139,635 samples collected from antenatal women. Six thousand nine hundred and fourteen (5%) Rh-negative women were screened for Rh antibodies using an enzyme technique. Analysis was carried out by dividing the data into four groups, each of three years duration. RESULTS. The number of women attending the antenatal outpatients increased steadily but the frequency of Rh-negativity remained at approximately 5%. The rate of Rh immunization among Rh-negative women declined from 3.1% during 1981-83 to 1.7% during 1990-92. The rate among pregnant women dropped from 0.16% to 0.09% and this was statistically significant (p < 0.05). The incidence of Rh immunization among Rh-negative women increased from 0.4% in the first pregnancy to 17.5% after four or more pregnancies (p < 0.01). Only 15 out of 167 Rh immunized women had received anti-D immunoglobulin previously. CONCLUSIONS. The incidence of Rh immunization has declined during the last 12 years possibly due to family planning and extensive use of anti-D immunoglobulin. However, complete eradication of Rh haemolytic disease of the newborn will be possible only if a comprehensive Rh prophylaxis programme is instituted.


Asunto(s)
Anticuerpos/uso terapéutico , Femenino , Humanos , Inmunoglobulina D/inmunología , Incidencia , India/epidemiología , Paridad , Embarazo , Estudios Retrospectivos , Isoinmunización Rh/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA